Kremer Hovinga Strebel
111  Ergebnisse:
Personensuche X
?
1

Caplacizumab improves clinical outcomes and is well tolerat..:

Pavenski, Katerina ; Scully, Marie ; Coppo, Paul...
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  5 - p. 102512 , 2024
 
?
7

PB0279 Intermediate- and High-Risk Pulmonary Embolism in Pe..:

Balkom, K. ; Klaassen, I. ; Smiers, F....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101432 , 2023
 
?
8

PB0302 Preventing Thrombosis in Moderate-Severe Protein C D..:

Kremer Hovinga, I. ; Fischer, K.
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101413 , 2023
 
?
11

PB0621 Emicizumab Plasma Concentrations are not Related to ..:

van der Zwet, K. ; van Vulpen, L. ; van der Valk, P....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101206 , 2023
 
?
15

Long‐term follow‐up of patients treated with caplacizumab a..:

Scully, Marie ; de la Rubia, Javier ; Pavenski, Katerina...
Journal of Thrombosis and Haemostasis.  20 (2022)  12 - p. 2810-2822 , 2022
 
1-15